Search Results for "Accuvein Fda Approval"
Original Source: AccuVein, Inc.
AccuVein Inc. is a global leader in vein illumination. Its breakthrough product, the AV300, allows health care professionals to see a map of peripheral veins on the skinâs surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation.
Matching Channels
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...
Clinical Approvals - news, views, reports and blogs
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in e...
Interleukin 6 IL 6 Receptor IL 6R
Although the causes of rheumatoid arthritis are not fully understood, constitutive overproduction of interleukin-6 (IL-6), a multifunctional cytokine that regulates immune response, inflammatory react...
Matching News
AccuVein Inc. Named Edison Awards Finalist
LONG ISLAND, NY--(Marketwired - April 02, 2013) - AccuVein Inc. (www.accuvein.com) has been named a 2013 Award Finalist in the internationally renowned Edison Awards™ Competition. The Edison awar...
Vein Illumination Leader Announces AccuVein AV400
LONG ISLAND, N.Y., March 4, 2013 (GLOBE NEWSWIRE) -- AccuVein Inc. today announced the launch of the AccuVein AV400 vein viewing system, the next generation of the breakthrough AccuVein AV300 vein il...
Vein Illumination Leader, AccuVein Inc. and PSS Enter Into Distribution Agreement
LONG ISLAND, N.Y., Feb. 26, 2013 (GLOBE NEWSWIRE) -- AccuVein Inc. announced today a distribution agreement with PSS. PSS will be the U.S. distributor of AccuVein's portable, non-contact vein illumin...
AccuVein Inc. Named Finalist for the 2013 Red Herring Top 100 Award
LONG ISLAND, NY--(Marketwired - May 08, 2013) - AccuVein Inc., the leader in vein illumination, announced today it had been selected as a finalist for Red Herring's Top 100 North America award, a pr...
AccuVein unveils new version of vein illumination device
AccuVein has released the AV400, an updated version of its vein illumination system that can visualize the vasculature up to -More-
Aflibercept gains new approval, recommendation
Aflibercept (Eylea, Regeneron) has gained FDA approval for treatment of macular edema following CRVO and recommendation for approval by the CHMP for treatment of neovascular AMD.
Chugai files for Japanese approval of T-DM1 in breast cancer
Less than six months after the antibody-drug conjugate was filed for approval in the US and EU, Roche's affiliate Chugai has made a regulatory submission for T-DM1 (trastuzumab emtansine) in Japan....
Comment on FDA: From Risk Aversion to Approval Activism by Ben Comer
Hi Andrew, thanks for your question. I'm not certain, but I think Sherman's reference to 26 months from discovery to approval was in the context of drug candidates designated as "breakthrough therapie...
Matching PubMed Articles
Objectives and Aims: To evaluate the efficacy of the AccuVein AV300 device in improving the first-time success rate of intravenous cannulation of anesthetized pediatric patients. Background: The...
The FDA has approved tenofovir-emtricitabine for use as HIV pre-exposure prophylaxis, but it is unknown how approval may affect PrEP acceptability among US men who have sex with men. We conducted 8 fo...
Lymphatico-venous anastomosis (LVA) is used to resolve lymph retention in lymphedema. However, the postoperative outcome of lower limb lymphedema is poorer than that for upper limb lymphedema, because...
Objective: To investigate the main aims of the post-approval randomized controlled trials (RCTs) on etanercept and the extent to which they were designed to gain more comparative information. Methods:...
Reporting Ethics Committee Approval in Public Administration Research.
While public administration research is thriving because of increased attention to social scientific rigor, lingering problems of methods and ethics remain. This article investigates the reporting of...
